Nicotinic acetylcholine receptor alpha-5, alpha-7, and alpha-9 subtypes (nAChR α5, α7, α9)

Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that mediate fast excitatory neurotransmission and modulate various physiological processes across the nervous and immune systems. The α5, α7, and α9 subtypes represent specific therapeutic targets within this family, each with distinct structural and functional profiles. The α5 subunit is an accessory protein that modulates the properties of heteromeric receptors; specific polymorphisms in the CHRNA5 gene are major risk factors for nicotine dependence and lung adenocarcinoma (PMID: 18414406). The α7 subtype is a homopentameric receptor with high calcium permeability that is critical for cognitive functions and the regulation of systemic inflammation via the cholinergic anti-inflammatory pathway (PMID: 21951971). The α9 subtype, typically forming α9α10 heteromers, is expressed in the inner ear hair cells and immune cells, serving as a target for the treatment of neuropathic pain and breast cancer (PMID: 25006037). Pharmacological intervention involves the use of agonists, antagonists, and allosteric modulators to achieve therapeutic effects while minimizing off-target toxicity associated with other nAChR subtypes.

Other names

CHRNA5CHRNA7CHRNA9Cholinergic receptor nicotinic alpha 5 subunitCholinergic receptor nicotinic alpha 7 subunitCholinergic receptor nicotinic alpha 9 subunitNeuronal acetylcholine receptor subunit alpha-5Neuronal acetylcholine receptor subunit alpha-7Neuronal acetylcholine receptor subunit alpha-9

These receptors function as ligand-gated cation channels. Upon binding of acetylcholine or exogenous agonists, the channel opens to allow the influx of sodium (Na+) and calcium (Ca2+) ions, leading to membrane depolarization and the activation of intracellular signaling pathways (PMID: 21836751). Drugs targeting these receptors act as agonists to enhance signaling, antagonists to block overactive pathways, or allosteric modulators to fine-tune receptor response (PMID: 25006037).